1. $CPIX +6%. Compelling value play I recently highlighted as a buy http://seekingalpha.com/article/3389275-defending-cumberland-pharmaceuticals-and-upgrading-to-a-buy-in-front-of-q2-earnings. Buyback working today it looks like

  2. $CPIX With MACD rising and %K line on top of %D line, the major rally of the stock may be finally coming. http://www.foxchart.com/index.php?symbol=cpix

  3. $CPIX Reported Earnings on 8/4 After Close. Since then, stock has dropped 5%. Will it continue? http://stocksearning.com/q.aspx?Sys=CPIX

  4. $CPIX: New SEC Filing for CPIX: Form 8-K, No. 0001628280-15-006326 http://stocknewsflow.com/1087294_000162828015006326_0001628280-15-006326

  5. These are the days when I like being a selective value biotech investor $AQXP +225%, $MEIP +8%, $TRGT +4%, $BOTA +3%, $ROKA flat, $CPIX flat

  6. $CPIX: Cumberland Pharmaceuticals Reports Second Quarter & Year To ... http://stockwires.com/cumberland-pharmaceuticals-reports-second-quarter-amp-year-to

  7. $CPIX Based on $3,356,633 for repurchase H1 and $1,711,802 Q1, company spent $1,644,831 and ~$7.31pps in Q2 (225k shr repurchase per CFO)

  8. $CPIX Acetadote encouraging (generic strong, new formulation key). Vaprisol poor. sNDA result, Boxaban data later in yr

  9. Now on to the $CPIX call. Looks like CEO may be listening to me: we have a heightened focus on our business development efforts

  10. Reading questions suggested regarding $CPIX cc transcript http://www.conferencecalltranscripts.org/include/?location=http://seekingalpha.com/article/3398565-cumberland-pharmaceuticals-cpix-ceo-a-j-kazimi-on-q2-2015-results-earnings-call-transcript

  11. Cumberland Pharmaceuticals announces earnings. $0.09 EPS. $8.90m revenue. $CPIX http://www.marketbeat.com/stocks/NASDAQ/CPIX/?RegistrationCode=SocialMedia-direct&DefaultTab=Earnings

  12. $CPIX results out. 0.09EPS, 8.9 mil rev, Caldolor revs light, Acetadote revs recovered from last Q https://finance.yahoo.com/news/cumberland-pharmaceuticals-reports-second-quarter-200500874.html

  13. $CPIX up 6% today into earnings. My piece defending and upgrading the name to a buy linked here: http://seekingalpha.com/article/3389275-defending-cumberland-pharmaceuticals-and-upgrading-to-a-buy-in-front-of-q2-earnings

  14. $CPIX ER on 8/4 After Close. SP were DOWN 12 times out of last 20 qtrs (60%) in Earnings reactions http://stocksearning.com/q.aspx?Sys=CPIX

  15. Defending $CPIX And Upgrading To A Buy Before Q2 Earnings @Daniel_Ward top voted idea today http://leveredreturns.com/marginhunt?idea=55bf614ac99036c900a174d7

  16. New research out: Defending Cumberland Pharmaceuticals $CPIX And Upgrading To A Buy In Front Of Q2 Earnings http://seekingalpha.com/article/3389275-defending-cumberland-pharmaceuticals-and-upgrading-to-a-buy-in-front-of-q2-earnings

  17. Cumberland Pharmaceuticals to release Q215 earnings on Tuesday. $CPIX http://www.dakotafinancialnews.com/cumberland-pharmaceuticals-cpix-to-release-quarterly-earnings-on-tuesday/306255/

  18. $CPIX $AKRX $MYL Digging deeply into Acetadote market...does there really need to be this many names for EDTA? Geez

  19. I will be putting out a $CPIX update piece before earnings next wk after the 20% decline since June 16

  20. $CPIX ER on 8/4 After Close. SP were DOWN 12 times out of last 20 qtrs (60%) in Earnings reactions http://stocksearning.com/q.aspx?Sys=CPIX

  21. Earnings announcement: $CPIX is scheduled to report quarterly earnings on Tue, Aug 4 2015

  22. May give $CPIX deep review this wknd. Didnt think Id see it back here. $AKRX causing overconcern regarding already declining acetadote revs?

  23. What a candle! Huge -12% move. Dropped $CPIX to hold month ago at 7.42. http://seekingalpha.com/article/3258975-cumberland-pharmaceuticals-love-the-company-but-upside-is-limited. Buyback tomorrow?

  24. $CPIX continues to trade at a discount to its peers $SUPN $BDSI $SCLN $ZGNX $VVUS $SCMP $DEPO $OREX $AMPH

  25. My new piece on $CPIX after the 50% move: Love The Company, But Upside Is Limited http://seekingalpha.com/article/3258975-cumberland-pharmaceuticals-love-the-company-but-upside-is-limited